论文部分内容阅读
发表在Am J Respir Crit Care Med杂志的一项新的随机研究表明,吸入性氟替卡松(Fluticasone,FC)治疗成人急性哮喘比静注氢化可的松更为有效。乌拉圭蒙特维多de las Fuerzas医院的Dr.Gustavo J Rodrigo指出,早在患者送急诊90分钟后就可见到这种区别,肺阻塞最严重的患者受益最大。Dr.Rodrigo指出,虽然一些研究都表明吸入性FC治疗急性哮喘有良好效果,但系统性给予皮质类固醇却被认为是标准治疗。以往这两种方法的随机试验都是在儿童中进行的。研究人员为比较这两种治疗方法,随机选定106名送到急
A new randomized study published in Am J Respir Crit Care Med magazine showed that inhaled fluticasone (FC) is more effective than intravenous cortisol in the treatment of adult acute asthma. Dr. Gustavo J Rodrigo of de las Fuerzas Hospital in Montevideo, Uruguay pointed out that this difference can be seen as early as 90 minutes after the patient was sent to the emergency department, and the patients with the most serious pulmonary obstruction benefit the most. Dr. Rodrigo pointed out that although some studies have shown that inhaled FC has a good effect in the treatment of acute asthma, systemic administration of corticosteroids is considered as standard treatment. In the past, both randomized trials were conducted in children. Researchers to compare the two treatment methods, randomly selected 106 sent to the emergency